Astiva Health plans direct listing IPO on the Nasdaq in Q1
This story has been updated to correct the name Astiva Health.
Astiva Health, an Orange, Calif., Medicare Advantage prescription drug plan provider based in Orange, Calif., said Friday it plans to register its common stock for trading on Nasdaq in an initial public offering, or IPO. Astiva Health said it's targeting a first-quarter debut of its stock with Spartan Capital as its underwriter. The company is planning to file a confidential draft registration statement with the Securities and Exchange Commission during the month of December. The company is not raising money by selling stock, but rather will register its shares for buying and selling on Nasdaq.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-18-23 1108ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
After Earnings, Is Coinbase Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued
-
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
Today’s Market Volatility Could Provide Tomorrow’s Opportunities
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth
-
The Best Gaming Stocks to Buy